In short
Oxaliplatin is a platinum-based chemotherapy drug that has shown promise in treating various types of cancer. This article explores the use of Oxaliplatin in clinical trials, focusing on its effectiveness, potential side effects, and combinations with other treatments for different cancer types.
At a glance
- Cancer Types Studied
- Colorectal, Gastric, Hepatocellular Carcinoma, Gastrointestinal, Breast
- Common Combinations
- FOLFOX, XELOX, with Capecitabine, Gemcitabine, Bevacizumab
- Administration
- Intravenous, often in cycles of 2-3 weeks
- Primary Outcomes
- Overall Survival, Progression-Free Survival, Response Rate
- Secondary Outcomes
- Safety Profile, Quality of Life, Time to Progression
- Potential Side Effects
- Neuropathy, Fatigue, Nausea, Vomiting, Diarrhea, Blood Cell Count Changes
- Special Considerations
- Renal Function, Pharmacokinetics, Immunogenicity
What is Oxaliplatin?
Oxaliplatin is a powerful chemotherapy drug used in the treatment of various types of cancer. It belongs to a class of medications known as platinum-based antineoplastic agents. Oxaliplatin works by damaging the DNA in cancer cells, which prevents them from dividing and ultimately leads to their death.
This medication is also known by other names, including:
- SR96669
- PLEOXTIN (645402430)
What Conditions Does Oxaliplatin Treat?
Oxaliplatin is primarily used to treat several types of cancer, including:
- Colorectal Cancer: This is the most common use of Oxaliplatin, particularly for metastatic colorectal cancer (cancer that has spread to other parts of the body).
- Esophageal Cancer: Oxaliplatin is used in advanced stages of esophageal cancer.
- Gastric (Stomach) Cancer: It's used in combination with other drugs for treating stomach cancer.
- Rectal Cancer: Oxaliplatin is part of treatment regimens for locally advanced rectal cancer.
- B-cell Lymphomas: In some cases, Oxaliplatin is used to treat certain types of lymphomas.
How is Oxaliplatin Administered?
Oxaliplatin is typically administered through intravenous (IV) infusion, which means it's given directly into a vein. The dosage and frequency can vary depending on the specific condition being treated and the patient's overall health. Here are some common administration methods:
- A typical dose is around 85-130 mg per square meter of body surface area.
- It's often given as a 2-hour infusion every 2 or 3 weeks.
- In some cases, it may be administered through hepatic arterial infusion, which means it's delivered directly to the liver. This method is sometimes used for liver metastases from colorectal cancer.
Oxaliplatin in Combination Therapies
Oxaliplatin is frequently used in combination with other chemotherapy drugs to enhance its effectiveness. Some common combination therapies include:
- FOLFOX: This regimen combines Oxaliplatin with 5-Fluorouracil (5-FU) and Leucovorin. It's commonly used for colorectal cancer.
- FOLFOXIRI: This more intensive regimen adds Irinotecan to the FOLFOX combination. It's used in some cases of metastatic colorectal cancer.
- Oxaliplatin with S-1: This combination is sometimes used in gastric cancer treatment.
- Oxaliplatin with Capecitabine: Another combination used in colorectal cancer treatment.
Potential Side Effects
Like all chemotherapy drugs, Oxaliplatin can cause side effects. It's important to discuss these with your healthcare provider. Some potential side effects include:
- Neuropathy: This is a common side effect that can cause tingling or numbness in hands and feet.
- Nausea and vomiting
- Fatigue
- Diarrhea
- Decreased blood cell counts, which can increase the risk of infection or bleeding
Current Research and Developments
Researchers continue to study Oxaliplatin to find new ways to use it effectively and minimize its side effects. Some areas of ongoing research include:
- Neoadjuvant therapy: Using Oxaliplatin before surgery in certain cancers to shrink tumors.
- Combination with targeted therapies: For example, combining Oxaliplatin with Bevacizumab in colorectal cancer treatment.
- Use in other types of cancer: Exploring its effectiveness in cancers where it's not commonly used.
Remember, while this information provides a general overview, your specific treatment plan may vary. Always consult with your healthcare provider for personalized information about your treatment with Oxaliplatin.